UK corporate updates delivered a wave of strong operational momentum and major strategic transactions today, led by robust financial performances from Applied Nutrition, which surged with a 50.9% revenue jump to £161.6m, and Ninety One, which boosted its assets under management to £181.4bn. High-value property transactions and regulatory milestones further anchored market activity, highlighted by Great Portland Estates agreeing to the £422.3m sale of 2 Aldermanbury Square to Rothesay and AstraZeneca securing European Commission approval for its rare disease drug, Klygefa. Meanwhile, balance sheet optimization and international expansion took center stage as ASOS agreed to buy back £90m of its convertible bonds, Legal & General reaffirmed its strategic targets backed by a 213% Solvency II ratio, and Coca-Cola HBC finalized approval for a fast-track secondary listing on the Johannesburg Stock Exchange.
In a third-quarter trading update, financial services provider Legal & General confirmed it remains on track to hit or surpass its medium-term strategic targets. The group saw its Solvency II capital ratio strengthen to 213% from 201% at the half-year, supported by steady expansion across core business lines. Institutional Retirement deals reached £6.7bn year-to-date, while Retail Workplace net flows totaled £8.0bn. Chief Executive António Simões noted that the structural simplification program launched in 2024 is creating a more efficient platform for future growth.
Building products distributor Grafton Group GFTU reported an acceleration in sales growth for the four months to 31 October 2026, with average daily like-for-like revenue rising 2.0% compared to 0.6% in the first half. Total year-to-date revenue expanded 7.4% to £2.29bn, supported by contributions from past acquisitions. Stronger demand across Iberia, Ireland, and Northern Europe helped counter persistent weakness in UK repair, maintenance, and homebuilding markets. Management reiterated its full-year adjusted operating profit forecast of £190m to £200m.
Instant-service equipment operator ME Group International MEGP issued a trading update for the financial year ended 31 October 2026, highlighted by sustained expansion in its Wash.ME unit. Laundry revenues are expected to increase 14% year-on-year, supported by 1,224 net new machine installations and a landmark partnership with ASDA targeting up to 700 UK sites. Photobooth demand remained stable across most geographic markets despite weather and geopolitical headwinds. The group confirmed overall trading remains in line with revised full-year adjusted profit before tax expectation of not less than approximately £66 million.
Sports nutrition and health brand Applied Nutrition APN published its preliminary results for the financial year ended 31 July 2026, delivering financial metrics in line with recently upgraded market expectations. Group revenue climbed 50.9% to £161.6m, while adjusted EBITDA increased 40.1% to £43.3m. Performance was driven by new product rollouts, broader retail distribution, and market share gains across core categories. Management indicated that operational momentum has continued strongly into the first quarter of FY27.
Central London property developer Great Portland Estates GPE has completed the sale of its prime office development at 2 Aldermanbury Square to Rothesay Life. The transaction closed at a net price of £368.7m after adjusting for tenant rent-free incentives, delivering a 3% premium over its March 2026 valuation. The 324,700 sq ft City office asset is fully leased to law firm Clifford Chance through 2046. Proceeds from the sale will initially pay down revolving credit facilities before being reinvested into the group's ongoing development pipeline.
Pharmaceutical major AstraZeneca AZN announced European Union regulatory approval for Klygefa as an add-on therapy for adult patients with generalized myasthenia gravis. The authorization follows a positive opinion from European regulators based on pivotal Phase III trial data showing significant improvements in daily living activity scores compared to placebo. Klygefa is the first dual-binding nanobody C5 inhibitor cleared in the region, offering once-weekly subcutaneous self-administration via autoinjector.
Flexible workplace and industrial park owner Sirius Real Estate SRE delivered solid financial growth for the six months ended 30 September 2026. Total revenue grew 17.9% to €191.4m, while funds from operations rose 11.9% to €72.4m, driven by organic rent roll expansion of 5.1% alongside strategic acquisitions across Germany and the UK. Profit before tax prior to property revaluations climbed 39.2% to €60.0m. The board approved a 5.3% increase in its interim dividend, marking 26 consecutive periods of dividend growth.
Online fashion retailer ASOS ASC has entered into an agreement to repurchase £90m in principal of its 11.00% guaranteed secured convertible bonds maturing in 2028. Following settlement, the repurchased debt will be cancelled, lowering the total outstanding principal from £253m to £163m. The transaction is funded directly from cash balances, which stood at £328.3m at year-end. Management noted that improved EBITDA generation—reaching £170.3m in FY26—allows the company to reduce borrowing costs and optimize its capital structure.
Anglo-South African asset manager Ninety One N91 reported half-year financial results for the period ended 30 September 2026. Closing assets under management climbed 19% year-on-year to £181.4bn, overcoming net institutional outflows of £4.2bn during the six months. Adjusted operating profit expanded 19% to £117.8m, supported by a margin improvement to 32.5%, while adjusted earnings per share rose 5% to 8.8p. Management emphasized progress in core strategic initiatives despite a challenging global asset management market.
Clean energy technology developer Ceres Power Holdings CWR has broadened its global footprint after securing a new licensing agreement for its solid oxide fuel cell technology in the EMEA market. The contract grants a privately held European energy technology company non-exclusive manufacturing rights for the Ceres Endura system, targeting power demands across data centres, industrial operations, and utilities. Ceres will receive high-margin licensing fees, engineering service revenue, and future royalties while expanding its commercial partner network.
Bottling group Coca-Cola HBC confirmed that the Johannesburg Stock Exchange has approved a fast-track secondary listing of its shares by introduction, with trading scheduled to commence on 23 November 2026. The secondary listing precedes the anticipated completion of its acquisition of Coca-Cola Beverages Africa on 27 November 2026. Following completion, Coca-Cola HBC will become the second-largest Coca-Cola bottler globally by volume, serving roughly 1.2 billion consumers across Europe and Africa.
High-performance polymer manufacturer Victrex VCT has named Adam Butcher as Chief Financial Officer and Executive Director, with his appointment taking effect on 15 February 2027. Butcher brings extensive finance and corporate transformation experience across global industrial groups, having held leadership roles at Honeywell Technologies, Rolls-Royce, Baker Hughes, and Wood Group. The appointment completes executive leadership changes under Chief Executive Dr James Routh as Victrex focuses on long-term growth.